SAMANTHA BARKER: Open Payments
NPI 1336805837 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 18 payments from 13 companies in 2025. Trend: 2023 $281 · 2024 $250 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $82 |
| Merck Sharp & Dohme LLC | 4 | $80 |
| ABBVIE INC. | 1 | $32 |
| Genmab U.S., Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| JAZZ PHARMACEUTICALS INC. | 1 | $25 |
| Geron Corporation | 1 | $24 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $23 |
| Stemline Therapeutics Inc. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
Products named: KEYTRUDA, Epkinly, MONJUVI, JAKAFI, LIBTAYO, ZEPZELCA, RYTELO, PYLARIFY.
Industry payments across TX — which companies pay providers there.
